| Title |
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
|
|---|---|
| Published in |
Frontiers in Pharmacology, July 2020
|
| DOI | 10.3389/fphar.2020.01071 |
| Pubmed ID | |
| Authors |
Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, Vijay Harypursat, Yan-Qiu Lu, Yan Wan, Lu Zhang, Qiang-Zhong Sun, Nan-Nan Sun, Gui-Xue Wang, Zhong-Ping Yang, Yao-Kai Chen |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 126 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 12% |
| Other | 12 | 10% |
| Researcher | 12 | 10% |
| Student > Master | 12 | 10% |
| Student > Ph. D. Student | 10 | 8% |
| Other | 23 | 18% |
| Unknown | 42 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 25% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 10% |
| Nursing and Health Professions | 9 | 7% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Psychology | 4 | 3% |
| Other | 18 | 14% |
| Unknown | 46 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2020.
All research outputs
#6,420,901
of 23,230,825 outputs
Outputs from Frontiers in Pharmacology
#2,662
of 16,658 outputs
Outputs of similar age
#138,357
of 396,836 outputs
Outputs of similar age from Frontiers in Pharmacology
#81
of 426 outputs
Altmetric has tracked 23,230,825 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 16,658 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 426 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.